Effect of Daily or weekly Glp-1 receptor Agonists on glycemic Control In Insulin-NaÏVe patients With Poorly Controlled type 2 Diabetes: a real-world study
| Autor: | Carrie McAdam-Marx, Sudhir Unni, David Cobden, Hiep Nguyen, Mukul Singhal, Marisa B. Schauerhamer |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
endocrine system
medicine.medical_specialty business.industry Health Policy Insulin medicine.medical_treatment digestive oral and skin physiology Public Health Environmental and Occupational Health Type 2 Diabetes Mellitus Type 2 diabetes Insulin naive medicine.disease Endocrinology Internal medicine Diabetes mellitus medicine Receptor business hormones hormone substitutes and hormone antagonists Glucagon-like peptide 1 receptor Glycemic |
| Zdroj: | Value in Health. 18:A54 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2015.03.317 |
| Popis: | • In patients with diabetes, poor glycemic control is associated with increased morbidity, mortality, and health care costs.1,2,3 • GLP-1 receptor agonists (GLP-1RA) have been shown to reduce HbA1c in patients with uncontrolled type 2 diabetes mellitus (T2DM).4,5 • There is limited data on once-weekly or once-daily GLP-1RA realworld outcomes in patients with uncontrolled or poorly controlled diabetes who are initiated on a GLP-1RA without prior insulin treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect